The specificity of GalNAc-transferase is consistent with the existence of an extended site composed of nine subsites, denoted by R4, R3, R,, R I , R,, R1., R2., R3,, and R4,, where the acceptor at R, is either Ser or Thr to which the reducing monosaccharide is being anchored. To predict whether a peptide will react with the enzyme to form a Ser-or Thr-conjugated glycopeptide, a new method has been proposed based on the vector-projection approach as well as the sequence-coupled principle. By incorporating the sequence-coupled effect among the subsites, the interaction mechanism among subsites during glycosylation can be reflected and, by using the vector projection approach, arbitrary assignment for insufficient experimental data can be avoided. The very high ratio of correct predictions versus total predictions for the data in both the training and the testing sets indicates that the method is self-consistent and efficient. It provides a rapid means for predicting 0-glycosylation and designing effective inhibitors of GalNAc-transferase, which might be useful for targeting drugs to specific sites in the body and for enzyme replacement therapy for the treatment of genetic disorders.
ful knowledge for targeting drugs and for enzyme replacement therapy for genetic disorders, and hence the field of glycoproteins has attracted researchers from a variety of disciplinesfrom chemistry to cancer research.
The most distinctive feature of glycoproteins is the carbohydrate-peptide linkage (Sharon & Lis, 1981) . For the rational design of drugs preventing the formation of this linkage, it is important to understand the linkage processes, particularly the mechanism and specificity of enzymes involved in glycosylation. The oligosaccharide side chains are covalently attached to the proteins at their Asn side chains (N-linked) or Thr/Ser side chains (0-linked) (Kobata, 1984; Kornfeld & Kornfeld, 1985) . Three types of 0-glycosidically linked oligosaccharides are commonly found in animal cells. A remarkable feature of these types is that the reducing monosaccharide is always conjugated to a Ser or Thr residue of the polypeptide, but the chemical nature of the anchoring monosaccharide and the size of the oligosaccharide unit vary from type to type. The first type is the smallest, with glycoconjugates consisting of a single N-acetylglucosamine residue linked to a Ser/Thr residue of certain cytoplasmic and nuclear proteins (Hart et al., 1988) . The second, considerably larger type is one in which a xylose residue is conjugated to a Ser residue of the protein backbone (Roden, 1966) to form glycosaminoglycans. In the third type of structure, an N-acetylgalactosamine residue at the reducing end of the oligosaccharide forms an 0-linkage to a Ser or Thr residue on the protein (Sadler, 1984) .
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The third type, often referred to as 0-linked or mucin-type oligosaccharides, is the focus of the current study because they are intimately involved in the secretion of proteins, be they enzymes, hormones, or structural glycoproteins. The biosynthesis of 0-linked oligosaccharides is catalyzed by a transferase specific for each type of 0-glycosylation. During the catalysis process, as illustrated in Figure 1 , a single monosaccharide is transferred from UDP-GalNAc (substrate 2 of Fig. IA ) to a specific amino acid Ro on the protein acceptor (substrate 1 of Fig. IB) . However, the acceptor specificity is not completely understood for any of these transferases. Nevertheless, it can be inferred from the acceptor substrate specificity of GalNActransferase, as deduced from the amino acid sequences sur- gosaccharides catalyzed by the GalNAc-transferase. During the catalysis process, a single monosaccharide is transferred from UDP-GalNAc (substrate 2, A) to a specific amino acid Ro on the protein acceptor (substrate I , B). The specificity of GalNAc-transferase is consistent with the existence of an extended site composed of nine subsites, denoted by R4, R,. R2, R,, Ro, R,,, Rz., R?., and RJ., where the central subsite Ro is printed in reversed type (i.e., white letters with black background). This is to distinguish it from the other subsites in the sense that the acceptor at Ro must be either Ser or Thr to which the reducing monosaccharide is being anchored during the process of 0-glycosylation. We use the symbol R rather than P, as originally used by Schechter and Berger (1967) . in order to avoid any confusion with the symbol P, introduced later for probability.
K.-C. Choll rounding 196 0-glycosylation sites ( Table I of Elhammer et al., 1993) extracted from the National Biomedical Research Foundation Protein Database (NBRF Protein Database, 1993) , that the glycosylated peptides have the reactive Ser or Thr in the central position, designated as Ro (Fig. 1) . Moving toward the NH2-terminus the subsites are designated as RI to R4 and those toward the COOH-terminus as subsites R,, to R4.. The reason I use the symbol R here, rather than the symbol P originally used by Schechter and Berger (l967) , is to avoid any confusion with the notation P introduced later for probability.
Knowledge of the specificity of GalNAc-transferase will refine our understanding of its specificity and the information thus acquired is useful for designing specific and efficient inhibitors against the enzyme to catalyze the formation of the carbohydrate-peptide linkage. It is instructive to elucidate this further by the following rationale. According to the "lock-andkey" mechanism in enzymology, the substrate of an enzyme must satisfy its specificity, i.e., a good fit for binding to the active site. Therefore, the specificity of GalNAc-transferase can help us to determine what kind of peptides can function as a competitive inhibitor against the enzyme and what kind of peptides cannot. Even for nonpeptide inhibitors, it can also provide useful insights about the key binding groups, proper microenvironment, and fitting conformation, as well as the requirement for hydrophobicity. Accordingly, in the search for potential inhibitors, a matter of primary importance is to discern what peptides do or do not satisfy the specificity of the enzyme. Even limited in the range of a nonapeptide with either Ser or Thr at the central position (Fig. I) , it is by no means easy to answer the question. This is because the number of possible nonapeptides thus formed from 20 amino acids runs into 2 X 20' = 5.12 X IO"'. This is an astronomical figure! It would be exhausting to experimentally test out so many nonapeptides. On the other hand, it would be very useful and would speed our pace in the search for proper inhibitors of GalNAc-transferase if we could find an accurate and rapid method for predicting what peptides belong to the substrate of the enzyme.
Recently, based on the 196 glycosylated peptides as well as the the cumulative enzyme specificity model (Poorman et al., 1991) , a method has been developed (Elhammer et al., 1993) for predicting the acceptor substrate specificity of GalNActransferase. The model postulates independent interactions of the nine sequence-contiguous amino acid moieties with their respective binding sites on the transferase. This model may be designated as the h-function method because glycosylation prob- 0, l', 2', 3', 4') subsite for a given training set of substrates. One set of si,, values is given in Table 4 of Elhammer et al. (1993) .
In Equation 1, the parameter 56 and the cutoff value h,. = 0.19 were obtained only from crude, subjective estimations in order to achieve the best compromise between overpredictions and underpredictions. The rate of correct predictions for the 196 glycosylated peptides of the training set was 153/196 = 78.1%. For an enzyme of such complex and unusual specificity these results should be deemed promising. In particular, their results suggest that the specificity of the enzyme is not directed toward any particular secondary structure but depends strongly on the accessibility of this segment, Furthermore, as addressed by them, the strongest interactions of the enzyme with the substrate are the binding and positioning of the reactive Ser or Thr residue and the interaction with the peptide backbone, presumably by hydrogen bond formation. Only extended conformations of the peptide backbone would be conducive to hydrogen bond formation and the a-helix would be the most refractory. Their discussion suggests that the broad specificity of GalNAc-transferase is the consequence of an extended binding site. These findings have provided quite useful insights to the study of this field.
However, the h function method suffers from some intrinsic weakness, as reflected by the following facts. First, in calculating the h function, the probability of an amino acid occurring in each of the eight specificity subsites was treated as a completely independent event. In other words, not even the most neighboring coupling effect was taken into account along the peptide sequence. Obviously, this will certainly affect the accuracy of prediction, as borne out in a previous paper (Chou, 1993) , where the accuracy of predicting the cleavage sites in proteins by HIV protease has been significantly improved after incorporating such a coupling effect. Second, the h function was a multiplication of s ; ,~ (Equation 1). When the frequency of the j t h amino acid occurring at the ith subsite is zero, an arbitrary value such as 0.01, 0.03, or 0.04 had to be assigned for the corresponding s; , (see Tables 2, 4 of Elhammer et al., 1994) ; otherwise, the h value would become zero no matter how favorable the specificity indices of the amino acids at the remaining subsites. The choice of these arbitrary s; , , values might unduly influence the calculated results of h. Third, it should be noted that in the h function method no clear procedure was described in determining the "cutoff value," a critical quantity in predicting the reactivity of an oligopeptide. The ambiguous treatment of such a critical quantity might introduce even more arbitrariness. In view of the above problems, can we develop a statistically more reasonable method, by which the intersubsite coupling effect is taken into account but the assignment of arbitrary values for insufficient experimental data can be avoided, and with which prediction with a higher accurate index can be obtained? To tackle these probIems, this article is devoted to a new approach, the sequence-coupled vector-projection model, and to compare the efficiency of the new method with that of the h function method.
Method
A GalNAc-transferase has an extended active site (Schechter & Berger, 1967; Elhammer et al., 1993) . If one postulates that the substrate interacts with the enzyme's nine amino acid subsites with the central subsite being specific for Ser or Thr, then the amino acids interacting with the enzyme may be represented as: x~x~x~x~x~x ,~x~x~~x 4 . , (2) where X4 represents the amino acid at position R4, X3 the amino acid at position R3, and so forth. For studying the spec-ificity of the enzyme, oligopeptides can be classified into two categories: the positive set and the negative set. The positive set, denoted by S', consists of oligopeptides that can be glycosylated by the enzyme, whereas the negative set, S-, consists of unreactive ones.
Given a nonapeptide, its assignment to the positive set S + or the negative set S -can be formulated by a 9D (nine-dimension) vector. If the amino acid residue at each of the nine subsites can be treated as an independent element, i.e., there is no coupling at all among these subsites, then its assignment to S + and that to S -can be expressed, respectively, as where P:(X;) (i = 4, 3, 2, 1, 0, l', 2', 3', 4') is the probability of amino acid X; occurring at subsite Ri in the positive set S', and its value can be derived from a set of training data consisting of only the reactive peptides known to be glycosylated by GalNAc-transferase. P;(X,) in Equation 3B has the same meaning as P:(X;) of Equation 3A except that it is associated with the negative set S-, and its value should be derived from a set of training data consisting of only the unreactive peptides known to be not glycosylated by the enzyme. The subscript 0 of V indicates that the components of the 9D vector are formed by nine independent probabilities in which no coupling effect between subunits is included, as shown by the right side of Equation 3. These independent probabilities actually correspond to the zero-order coupled terms.
However, if the coupling effect of a residue with its closest neighboring residue (Fig. 1) must be taken into account, then the matrix elements in Equation 3 should be modified according to the first-order Markov chain theory (Bhat, 1984) , i.e., substituted by the first-order conditional probabilities. For consistency, the corresponding vector symbol Vo in Equation 3 should also be changed to V I , or simply to V. Thus, instead of Equation 3A, we should have vo+(x~x~x~x~xoxI'x2'x,'x4.) = where P4+(X4) is the same as in Equation 3A, i.e., the probability of amino acid X, occurring at subsite position R4 in the positive set S+ and it is independent of the other subsites because R4 is located at the first position of the nine-subsite sequence (Fig. l) , and P2(X31X4) is the probability of amino acid X3 occurring at the subsite R3 given that X4 has occurred at position R,, P,'(X2 I X,) is the probability of amino acid X2 occurring at the subsite R2 given that X, has occurred at position R,, and so forth. Similarly, instead of Equation 3B we should have v-(x4x~x2x,xoxI~x2rx3~x4) = where all the elements have the same meaning as those of Equation 4A except that they are associated with the negative set Sand their values should be derived from a set of training data consisting of only the unreactive peptides.
Generally speaking, if the coupling effects of the I (I = 2, 3 , . . .) closest neighboring amino acid residues need to be considered, then Equation 3 should be modified according to the Ith-order Markov chain theory, i.e., the vector symbol Vo should be replaced by V, and the corresponding matrix elements by the Ith-order conditional probabilities. As one could surmise, the analysis of a higher-order Markov chain would be much more complicated. Therefore, the treatment in this paper is confined to the first-order Markov chain; i.e., only the firstorder sequence-coupling effect is taken into account, as formulated by Equation 4. Now, in the 9D space, let us define an ideal specificity-positive vector , A+, each of whose nine components h: ( i = 4, 3, 2, 1, 0, l', 2', 3', 4') is the upper limit of the corresponding matrix element in Equation 4A. Theoretically, the upper limit is 1, meaning that A+ would be the vector for a K.-C. Chou hypothetical, idealized oligopeptide that would be the only reactive peptide for the enzyme. Therefore, for such an ideal specificity-positive vector A+, all of its components are equal to 1. The similarity in the specificity-positive attribute between a given nonapeptide and the idealized reactive peptide can be expressed in terms of the projection of V+ on A+. The larger the projection, the higher the similarity, and hence the closer the peptide to the specificity-positive set. This is the so-called maximum-vector-projection principle, or maximum-correlationcoefficient principle (Chou & Zhang, 1992) , which has proved to be quite successful when used to predict the structural class of a protein from its amino acid composition. Accordingly, the attribute function of a given nonapeptide to the specificitypositive set can be formulated by *+(x4x3x2xIxoxI'x2'x3.x4') = v+.A+ = P:(x,) p:(x3 I x41 p,'(x2 I x31 P:(XI 1 x2) + P,+(X,(X,) + P;(x]Jlxo) + P$(X,.(X,.) + P:(x,,Ix2.) + P;(x4'Ix3').
(5'4)
On the other hand, we can also in the 9D space define an ideal specificity-negative vector, A-, each of whose nine components X; ( i = 4, 3, 2, 1, 0, l', 2', 3', 4') is the upper limit of the corresponding matrix element in Equation 4B. Theoretically, the upper limit is also 1, meaning that A-would be the vector for a hypothetical, idealized oligopeptide, which would be the only unreactive peptide for the enzyme. Thus, it follows according to the similar rationale that the attribute function of a given nonapeptide to the specificity-negative set can be formulated by *-(x4x3x2xIxoxI~x2rx3.x4) = V -. A-= PT(x4) + p;(x3 I x4) + pT(x2 \ x , ) + P;(XI \ x , ) + P,-(X,IX,) + P;(xl,lxo) + P,(X2,IX,.) + P?(X3' I X2,) + P4;(X4' 1 Xy).
(93)
For a given nonapeptide X4X3X2Xl)6XI,X2.X3,X4, if its attribute function to the specificity-positive set is greater than that to the specificity-negative set, i.e., *+ > q-, then the peptide is predicted to be a reactive one; otherwise, it is predicted to be an unreactive one. Define a discriminant function A given by A(X4X3X2XIXoXI,X2,X3,X4,) = *+(X4X3X2XIXOXI'X2'X3'X4') -\k-(X4X3X2X,XoXI,X2,X3,X4.) + % ( X o ) , (6) where %(X,) = 0 when X, = Ser or Thr; otherwise, it should be a large negative number to guarantee A < 0. The parameter %(Xo) thus introduced reflects the fact that only those peptides with either Ser or Thr at the subsite Ro (Fig. 1) can be glycosylated by the GalNAc-transferase, as described at the beginning. Thus, the criterion for predicting the substrate specificity of a peptide can be formulated in terms of its discriminant function A as follows: A peptide cannot be glycosylated by the GalNAc-transferase, otherwise. (7) If, occasionally, the peptide to deal with is shorter than a nonapeptide, such as for the case of an octapeptide or heptapeptide (Elhammer et al., 1993) , one can simply set zero for the probability term of the absent residue. For example, if the peptide to be predicted is X3X2X1&XIfX2,X3,, then in Equations 4-6, one should substitute zero for P'(X,), P-(X,), P$(X4,1X39). and P4;(X4. 1 X3,) because there is no residue at the subsites R4 and R,, for the peptide concerned. Also, substitute P+(X3) for P:(X3 (X,) and P-(X3) for P<(X, (X,) because, in this case, any coupling associated with subsite R, would vanish.
A question might be posed. For a substrate with an extended backbone conformation, the interactions between two alternative subsites along the sequence should be greater than those between two adjacent ones. Can the new algorithm as formulated by Equation 5 reflect such a character as featured by a peptide with an extended backbone conformation? The answer is yes. This is because the current model is based on the Markov chain theory (Bhat, 1984) , according to which the alternate-subsitecoupled effect is indirectly reflected. To make this clearer, let us give an illustration through a simplified case. According to the sequence-coupled model (see Equation 5), the coupling effect for a segment of three amino acid sequence X,-IXiX,+I is given by On the other hand, according to the alternate-subsite-coupled model, the coupling effect for the same sequence should be expressed by Because of the normalization of conditional probabilities, it follows that where X , represents any amino acid at subsite i and the summation is carried out over all the 20 amino acids. The above equation indicates that the alternate-subsite-coupled effect can be derived from the sequence-coupled effect, and hence the alternate-subsite-coupled model is only a special case of the sequence-coupled model. Accordingly, compared with the alternate-subsite-coupled model, the current model is more essential and general. It incorporates not only the coupling effect between subsites with adjacent positions but also that with alternative positions. In other words, more effects are taken into account in the sequence-coupled model than the alternatesubsite-coupled model. This is also reflected by the following fact. When the sequence-coupling model (Chou, 1993) and the alternate-subsite-coupled model (Zhang & Chou, 1994) were used to predict the cleavage sites in proteins by HIV protease (whose substrates is also with an extended backbone conformation), the results thus obtained were quite similar and consistent, although the result by the former is slightly better than that by the latter. This is because the alternate-subsite-coupled model is an approximate case of the sequence-coupled model, Le., the case when the coupling effect between immediately adjacent subsites is ignored.
Results and discussion
In order to calculate the attribute functions 9+ for any nonapeptide, we have to first findPi+(X) (i = 4,3,2, 1,0, 1 ' , 2', 3', 4'), as well as P:(X3 I X,), Pz+(X2 I P:(Xl I X d , %(Xo I XI), P;(X,.(&), P;(X2rIXl,), P-,?(X3.1X2,), P$(X4'IX3,). These we derive from a positive training set consisting of 195 glycosylated peptides (Table l ) extracted from the NBRF Database (1993) . Note that here we selected 195 rather than 196 peptides as done by Elhammer et al. (1993) because, of the 196 peptides extracted by them, two have the identical sequence GPVV-T-AQYE. To avoid any duplication in the training set data, one of them should be removed.
In order to calculate the attribute functions 9-for any nonapeptide, we have to find P;(X) (i = 4, 3, 2, 1, 0, I', 2', 3', 4'), as well as P;(X31X4), PF(X2IXd, P W I 1x21, P;(XoIXl), Pl,(X,.]&), P,;(X2.1X1,), PF(X3,1X2,), P4;(X4,1X3,). These we derive from a negative training set consisting of all nonapeptides with either Ser or Thr at Ro (Fig. 1) from the following nine nonglycosylated proteins: porcine cytochrome c, human plasma apolipoprotein A-I, human calcineurin B subunit, human glucagon, porcine insulin A-chain, porcine insulin B-chain, porcine elastase, bovine pancreatic trypsin inhibitor, and (Ycobratoxin. There is a total of 110 such unreactive peptides as listed in Table 2 .
The computations were carried out on an IBM 3090/400J computer at Upjohn Laboratories. Listed in Table 3 are the probability values for Pi+(X) (i = 4, 3, 2, 1, 0, l', 2', 3', 4') derived from the 195 glycosylated peptides (Table l) , and the relevant conditional probabilities, which contain 20 x 20 x 8 = 3,200 data points, are given in Appendix 1. Listed in Table 4 are the probability values for P;(X) (i = 4, 3, 2, 1, 0, l', 2', 3: 4') derived from the 110 unreactive peptides (Table 2) , and the relevant conditional probabilities, which also contain 20 X 20 x 8 = 3,200 data points, are given in Appendix 2.
Based on the data in Tables 3 and 4 and Appendices 1 and 2, the discriminant function A for any given peptide X4X3X2XlXoXI, X2,X3,X4, can be calculated by means of Equations 5 and 6, and its specificity can be predicted according to Equation 7.
Predicted results for the training data
The prediction for the peptides in the training set can be used to examine the self-consistency of a method. The predicted results by the new method for the 195 peptides in the specificitypositive training set, together with those by the h function method, are given in Table 1 . As we can see, all these glycosylated peptides, except five, have A > 0, indicating that the rate of correct prediction for the specificity-positive training set is 190/195 = 97.4%. However, according to the h function method, 41 of them have h < 0.19, meaning that the rate of correct prediction is only 150/195 = 79.0%. The predicted results for the specificity-negative set are given in Table 2 , from which we can see that the rates of correct prediction for the 110 unreactive pep- Elhammer et al. (1993) because it was found that two peptides there had the same sequence, GPVV-T-AQYE, and hence one of them has been removed to avoid any duplication.
A is the criterion used in this paper for predicting whether an oligopeptide can be glycosylated by GalNAc-transferase: an oligopeptide can be glycosylated when its A 5 0; otherwise, it cannot be glycosylated. Values of A were calculated according to Equations 5 and 6.
h is the criterion used in the h function method (Elhammer et at., 1993) to predict whether an octapeptide can be glycosylated by GalNAc-transferase: an oligopeptide can be glycosylated when its h ? 0.19; otherwise, it cannot be glycosylated.
National tides are 100% by both methods. Accordingly, the new method is 18.4Vo higher than the h function method for predicting the peptides in the specificity-positive training set.
Predicted results for the testing data
The prediction for the testing peptides outside the training set will indicate the extrapolating effectiveness . However, in the paper by Elhammer et al. (1993) , no report was given about the prediction for a testing set. Listed in Table 5 are the predicted results for a set of testing data constructed according to the recent experimental reports (Oppenheim et al., 1985; Watzawick et al., 1992; Pisano et al., 1993) . The testing set consists of 30 oligopeptides. A peptide that can be glycosylated by GalNAc-transferase is marked by "+"; otherwise, it is marked marked by "-". It can be seen from Table 5 that compared with nine incorrect predictions by the h function method, there are only three by the new method. The rate of correct prediction is 70.0% for the former and 90.0% for the latter. Consequently, the new method is 20% higher than the h function method in predicting the specificity of the testing data.
The development of prediction methods based on statistical theory generally consists of two parts: one is focused on the exploration of new algorithms, and the other on the improvement of a training database. The current study belongs to the former.
Based on the same database, the higher success rates for both the training and testing sets by the new algorithm indicate that the new algorithm is better than the h function algorithm in both the self-consistency and extrapolating effectiveness. Therefore, with more and more experimental results accumulated in this area, the database will gradually be enlarged and improved, and the new algorithm will become a more and more reliable tool to predict the specificity of GalNAc-transferase.
Recently, the crystal structure of P-glucosyltransferase was reported by Vrielink et al. (1994) . Because GalNAc-transferase and 0-glucosyltransferase functionally belong to the same family, they might have a similar three-dimensional structure. If so, it is certainly worthy of our future study by inspecting the threedimensional structure of the complex between P-glucosyltransferase and UDP because this may provide useful insights about specificity of GalNAc-transferase at a deeper level.
Conclusion
What kind of peptide sequences can react with GalNAc-transferase to form a Ser-or Thr-conjugated glycopeptide, and what kind cannot? This is a problem with which one is often confronted in designing effective inhibitors of GalNAc-transferase. Therefore, it is highly desirable to develop a rapid and reliable means for predicting the specificity of GalNAc-transferase.
By means of the proposed new method, the rate of correct prediction for the 195 oligopeptides in the specificity-positive T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T   T  T   T  T   T  T  T  T  T   T   T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T a Although also with Ser or Thr at the central subsite Ro, these peptides were extracted from nine nonglycosylated proteins and hence can serve as a negative training set for studying the specificity of GalNAc-transferase. The nine nonglycosylated proteins are: porcine cytochrome c, human plasma apolipoprotein A-1, human calcineurin B subunit, human glucagon, porcine insulin A-chain, porcine insulin A-chain, porcine elastase, bovine pancreatic trypsin inhibitor, and a-cobratoxin.
See footnote b to Table I . See footnote c to 
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Amino acid X P 2 ( X ) P < ( X ) P;(X) P:(X) P:(X) P?(X) P $ ( X ) P ; ( X ) P ; ( X ) (Table 5) , which is 20% higher than that obtained by the h func-97.4% (Table l) , which is about 18% higher than that by the tion method for the same data set. h function method for the same set of data (Elhammer In addition to yielding better predicted results, the new method et al., 1993). The rate of correct prediction for the 110 unreacis also biochemically more reasonable and statistically more nattive peptides in the specificity-negative training set extracted ural, as reflected by an improvement in the following three asfrom the nine nonglycosylated proteins is 100% ( Table 2 ). The pects: (1) In contrast to the h function method in which amino rate of correct prediction for the peptides in the testing set is 90% acids in the nine subsites were treated completely independently, Aminoacid X P;(X) P c ( X ) P g ( X ) P ; ( X ) P f ( X ) P ; ( X ) &(X) P , ( X ) P4;(X) a The sequence position of the conjugate residue (S or T) in the protein from which the peptide is extracted.
Experimental observation of the specificity to GalNAc-transferase: + means specificity-satisfied peptide; -means specificity-unsatisfied peptide.
See footnote b to Table 1 . See footnote c to Table 1 . eGpA, human glycophorin A (Pisano et al., 1993) .
g2HSg, a-2HS-glycoprotein (Watzawick et al., 1992) . MRRP, macaque proline-rich phosphoglycoprotein (Oppenheim et al., 1985) .
in the sequence-coupled vector-projection model the coupling effects between neighboring subsites were taken into account.
(2) Unlike the h function method in which some arbitrary values must be assigned for some low-abundance residues, there is no such intrinsic weakness for the current method; the problem caused by such arbitrary assignments is particularly serious when the data in the training set are limited. (3) Finally, the clearly defined discriminant function A as a criterion in the current method for predicting the specificity (see Equations 6 , 7) can avoid a crude, subjective estimation for the cutoff value h, as done in the h function method, which provides additional merit to the current method. 1 X,) , where X I represents the amino acids along the row, and X, the amino acids along the column 
